LOS ANGELES CAPITAL MANAGEMENT LLC

Position in GH — Guardant Health, Inc.

CIK 1177206 LOS ANGELES, CA

Position in GH

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$994,455

+$61,917 QoQ

Shares Held

10,766

+17.9% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 8.889095300018578.ToString("F0")% Shared 0.ToString("F0")% None 91.11090469998142.ToString("F0")%

Healthcare · as of Mar 31, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $165,105,550 across 27 Diagnostics & Research names. GH ranks #6 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IDXX	Idexx Laboratories Inc /De	227,369	$127,756,367
2	MEDP	Medpace Holdings, Inc.	45,686	$21,937,960
3	IQV	Iqvia Holdings Inc.	33,168	$5,656,470
4	VCYT	Veracyte, Inc.	91,401	$2,944,026
5	SHC	Sotera Health Co	120,851	$1,733,003
6	GH	Guardant Health, Inc. This page	10,766	$994,455
7	TMO	Thermo Fisher Scientific Inc.	1,631	$801,685
8	WGS	GeneDx Holdings Corp.	10,103	$648,814

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$994,455	10,766	+17.9%	Shares	Sole	2026-05-08
2025-12-31	$932,538	9,130	-38.3%	Shares	Sole	2026-02-11
2023-12-31	$400,150	14,793	+27.8%	Shares	Sole	2024-02-06
2023-09-30	$343,083	11,575	-27.0%	Shares	Sole	2023-11-06
2023-06-30	$567,788	15,860	+628.2%	Shares	Sole	2023-08-03
2021-12-31	$217,843	2,178	-4.8%	Shares	Sole	2022-02-03
2021-09-30	$286,022	2,288	-32.0%	Shares	Sole	2021-11-08
2021-06-30	$417,650	3,363	0.0%	Shares	Sole	2021-08-05
2021-03-31	$513,361	3,363	-22.6%	Shares	Sole	2021-05-05
2020-12-31	$559,725	4,343	+58.8%	Shares	Sole	2021-03-10
2020-09-30	$305,718	2,735	+7.0%	Shares	Sole	2020-11-02
2020-06-30	$207,287	2,555	—	Shares	Sole	2020-08-05
No filing history on record for this holder in this stock.